Is MCET or VYM a better dividend investment in 2026?

MCET currently yields 20000000.00% with a 5% 5-year dividend growth rate. VYM yields 2.41% with 7.8% growth. The better choice depends on your goal: MCET offers higher current income.

What is the dividend yield difference between MCET and VYM?

MCET has a forward dividend yield of 20000000.00% ($2.00/share annually). VYM yields 2.41% ($3.51/share annually). The yield gap is 19999997.59 percentage points.

Home › Compare › MCET vs VYM

MCET vs VYM: Dividend Comparison 2026

MCET yields 20000000.00% · VYM yields 2.41%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MCET wins by $4.875981653489057e+49M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MCET

● Live price

20000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.875981653489057e+49M

Annual income

$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00

Full MCET calculator →

VYM

Vanguard High Dividend Yield ETF

● Live price

2.41%

Share price

$145.48

Annual div

$3.51

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.8K

Annual income

$278.55

Full VYM calculator →

Portfolio growth — MCET vs VYM

📍 MCET pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MCET	VYM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MCET + VYM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MCET pays

VYM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCET

Annual income on $10K today (after 15% tax)

$1,700,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

VYM

Annual income on $10K today (after 15% tax)

$205.23/yr

After 10yr DRIP, annual income (after tax)

$236.77/yr

At 15% tax rate, MCET beats the other by $41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCET + VYM for your $10,000?

MCET: 50%VYM: 50%

100% VYM50/50100% MCET

Portfolio after 10yr

$2.4379908267445285e+49M

Annual income

$24,379,668,474,955,630,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

100.00%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCET buys

VYM buys

No recent congressional trades found for MCET or VYM in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMCETVYM

Forward yield	20000000.00% ✓	2.41%
Annual dividend / share	$2.00	$3.51 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.875981653489057e+49M	$27.8K ✓
Annual income after 10y	$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓	$278.55
Total dividends collected	$4.875978515990276e+49M ✓	$2.6K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: MCET vs VYM ($10,000, DRIP)

Year	MCET Portfolio	MCET Income/yr	VYM Portfolio	VYM Income/yr	Gap
1← crossover	$2,000,010,700	$2,000,000,000.00	$11,151	$241.44	+$2000.00M → MCET
2	$373,835,915,712,384	$373,833,775,700,934.50	$12,413	$246.79	+$373835915.70M → MCET
3	$65,304,953,364,964,970,000	$65,304,553,360,535,160,000.00	$13,794	$251.79	+$65304953364964.95M → MCET
4	$10,661,728,832,755,500,000,000,000	$10,661,658,956,455,399,000,000,000.00	$15,306	$256.47	+$10661728832755499008.00M → MCET
5	$1,626,767,783,781,495,000,000,000,000,000	$1,626,756,375,731,643,800,000,000,000,000.00	$16,960	$260.84	+$1.626767783781495e+24M → MCET
6	$231,974,330,054,625,100,000,000,000,000,000,000	$231,972,589,413,096,470,000,000,000,000,000,000.00	$18,768	$264.92	+$2.319743300546251e+29M → MCET
7	$30,915,106,403,922,057,000,000,000,000,000,000,000,000	$30,914,858,191,388,900,000,000,000,000,000,000,000,000.00	$20,745	$268.71	+$3.0915106403922057e+34M → MCET
8	$3,850,507,985,839,278,000,000,000,000,000,000,000,000,000,000	$3,850,474,906,675,425,000,000,000,000,000,000,000,000,000,000.00	$22,905	$272.24	+$3.8505079858392777e+39M → MCET
9	$448,210,261,035,314,200,000,000,000,000,000,000,000,000,000,000,000	$448,206,140,991,769,400,000,000,000,000,000,000,000,000,000,000,000.00	$25,265	$275.51	+$4.4821026103531426e+44M → MCET
10	$48,759,816,534,890,570,000,000,000,000,000,000,000,000,000,000,000,000,000	$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00	$27,842	$278.55	+$4.875981653489057e+49M → MCET

MCET vs VYM: Complete Analysis 2026

MCET — Stock

MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.

Full MCET Calculator →

VYM — ETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →

📬

Get this MCET vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCET vs SCHD MCET vs JEPI MCET vs O MCET vs KO MCET vs MAIN MCET vs VIG MCET vs DGRO MCET vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.